While Ozempic is only licensed in the UK for people with diabetes, the jabs have been prescribed off-label to people hoping to make use of its weight-loss properties while the rollout of Wegovy to treat obesity on the NHS has been delayed indefinitely
The practical implication is that researchers studying body composition outcomes not just scale weight may find retatrutides mechanism more aligned with favorable recomposition
Guo, C., Huang, T., Chen, A., Chen, X., Wang, L., Shen, F., & Gu, X
No commitment: Month-to-month billing
Cells belonging to resolution 1 clusters, where less than 20% of the published AP-centric neuronal populations mapped to were removed from the DVC neuronal atlas